TICKER INTELLIGENCE
BioNTech SE ($BNTX)
NYSE/NASDAQ: BNTX
Washington Intelligence
0
Active Bills
2
Gov't Contracts
7
Congressional Trades
$BNTX is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 2 active Congressional signals mentioning $BNTX, including 0 bills and 2 federal contracts. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.
Congressional Trades in $BNTX
7 filings⚠ System: No suspicious timing patterns detected
⚠ Rep. Gottheimer sold $1K-$15K in MSFT on Sept 12, 2024 — 17 days after Deloitte secured a $66.8M VA cybersecurity contract. While the contract went to a private firm, Microsoft is a major government IT contractor and the sale occurred shortly after a large federal cybersecurity award.
⚠ Rep. Gottheimer bought and sold $15K-$50K in MSFT on August 12, 2024 — 14 days before Deloitte & Touche secured a $66.8M VA cybersecurity contract. While Microsoft is not the direct contractor, the timing of both a buy and sell before a neutral-signal award is unusual.
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
⚠ System: No suspicious timing patterns detected
Federal Contracts Awarded to $BNTX
2 foundADVANCED TECHNOLOGY INTERNATIONAL: $19.6M Department of Health and Human Services Contract
This $19.6 million contract to Advanced Technology International (ATI) for CBRN AVAT_MRNA research is a positive signal for the biotechnology sector, particularly companies involved in mRNA technology, but its direct impact on publicly traded entities is indirect as ATI is a private entity.
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
This $304M contract to Advanced Technology International (ATI) for drug substance and product production under the BIOMAP-Consortium is a significant boost for the pharmaceutical manufacturing sector, directly benefiting companies involved in biopharmaceutical production and potentially their equipment suppliers. While ATI is private, this award signals continued government investment in domestic biomanufacturing capabilities, creating a favorable environment for publicly traded pharmaceutical and biotech companies.
Related Sectors
Understanding These Signals
Get Full Access to BioNTech SE ($BNTX) Signals
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →